Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).

Completed

Conditions studied: HIV Infection

In brief

This is a prospective observational cohort sub-study of subjects enrolled in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110 (NCT01772823) or ATN 113 (NCT01769456), which is a prospective interventional trial.

Key facts

Study ID

NCT01769469

Run by

University of North Carolina, Chapel Hill

People needed

101

Starts

2012-11-01

Expected to finish

2015-11-01

Last updated by the study team

2019-03-27

Who can join

Age: 15 and older, up to 22. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Has been enrolled in ATN 110 (NCT01772823) or ATN 113 (NCT01769456) , and
• Willing and able to provide written informed consent

You may not qualify if…

• Subjects exempted from undergoing DXA scans in ATN 110 (NCT01772823) or ATN 113 (NCT01769456) are not eligible to enroll in ATN 117 (NCT01769469).

Where it is running

• Children's Hopsital of Los Angeles — Los Angeles, California, United States
• Children's Hospital of Denver — Aurora, Colorado, United States
• University of Miami — Miami, Florida, United States
• University of South Florida — Tampa, Florida, United States
• Stroger Hospital and the CORE Center — Chicago, Illinois, United States
• Tulane University — New Orleans, Louisiana, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Fenway Institute — Boston, Massachusetts, United States
• Wayne State University — Detroit, Michigan, United States
• Children's Hopsital of Philadelphia — Philadelphia, Pennsylvania, United States
• St. Jude Childrens Research Hospital — Memphis, Tennessee, United States
• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.